1-4 of 4
Chris Sinclair, PhD, MBA
Close
Sort by
Journal Articles

Acute Hemolytic Reactions Reported in ITP Patients Treated with Rh o (D) Immune Globulin: Symptom Onset and Does Prior Exposure Lessen the Risk?

Carmen Muller, MD, Gregg Little, RPh, MBA, Kristen Hess, PharmD, Chris Sinclair, PhD, MBA
Journal: Blood
Blood (2011) 118 (21): 4670.
https://doi.org/10.1182/blood.V118.21.4670.4670
Published: 2011
Journal Articles

Potential Identification of High Risk Populations for Acute Hemolytic Reactions Following Rh 0 (D) Immune Globulin.

Paraneedharan Ramachandran, MD, Daniel Li, MSc, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 3685.
https://doi.org/10.1182/blood.V116.21.3685.3685
Published: 2010
Journal Articles

Which Hematological Malignancies Are Implicated In Acute Hemolytic Reactions Following Rh (D) Immune Globulin for ITP

Hugo Astacio, MD, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 4670.
https://doi.org/10.1182/blood.V116.21.4670.4670
Published: 2010
Journal Articles

Are Communication Tools Effective in Increasing Reporting Rate of Acute Hemolytic Reactions (AHR) In ITP Patients Treated with Rh (D) Immune Globulin?

Faiz Guirgis, MD, Carmen Muller, MD, Gregg Little, RPh, Chris Sinclair, PhD, MBA, Maurice Genereux, MD
Journal: Blood
Blood (2010) 116 (21): 4677.
https://doi.org/10.1182/blood.V116.21.4677.4677
Published: 2010